Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Aug 2026 for Supernus Pharmaceuticals, INC.. Read the official filing
Filing timeline
BuySaleJack A. Khattar
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jack A. Khattar: trading record in brief
Jack A. Khattar, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Supernus Pharmaceuticals, Inc., Cognition Therapeutics Inc and scPharmaceuticals Inc. We count 58 filings; the first trade dates from 30 July 2021 and the latest from 12 August 2026.
On the market, this insider has only ever bought: 1 purchase, €17k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 7 share grants and 44 option exercises.
The record was last updated on 14 August 2026 with an option exercise in Supernus Pharmaceuticals, Inc. The last purchase on record was published on 6 December 2021, which is 1,777 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jack A. Khattar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations58 total
29,849 shares0Common StockSEC:0001539937-26-000012:0
12,642 shares@ US$46.57Common StockSEC:0001539937-26-000012:1
25,000 sharesCommon StockSEC:0001104659-26-076477:0
12,500 sharesCommon StockSEC:0001539937-26-000008:0
38,640 shares0Common StockSEC:0001539937-26-000006:0
81,250 shares@ US$25.300.062% mcap22.8% of flowCommon StockSEC:0001628280-25-044830:0
5,000 sharesCommon StockSEC:0001193125-25-233528:0
20,000 shares0Common StockSEC:0001539937-25-000030:0
2,267 shares@ US$25.300.0017% mcap0.6% of flowCommon StockSEC:0001539937-25-000028:0
53,785 shares@ US$25.300.041% mcap14.9% of flowCommon StockSEC:0001539937-25-000026:0
11,510 shares@ US$25.300.0087% mcap3.2% of flowCommon StockSEC:0001539937-25-000024:0
13,688 shares@ US$25.303.0% of flowCommon StockSEC:0001539937-25-000022:0
47,940 shares@ US$12.985.3% of flowCommon StockSEC:0001539937-25-000020:0
27,060 shares@ US$12.983.3% of flowCommon StockSEC:0001539937-25-000018:0
8,074 shares@ US$25.302.0% of flowCommon StockSEC:0001539937-25-000014:0
73,176 shares@ US$25.3018.0% of flowCommon StockSEC:0001539937-25-000012:0
17,195 shares@ US$12.982.7% of flowCommon StockSEC:0001539937-25-000010:0
1,611 shares@ US$12.980.3% of flowCommon StockSEC:0001539937-25-000008:0
2,415 shares@ US$12.980.4% of flowCommon StockSEC:0001539937-25-000006:0
60,000 shares@ US$12.980.023% mcap8.6% of flowCommon StockSEC:0001628280-25-039302:0
34,000 shares0Common StockSEC:0001062993-25-012082:0
16,850 sharesCommon StockSEC:0001628280-25-016516:0
35,000 shares0Common StockSEC:0001628280-25-012005:0
38,640 shares0Common StockSEC:0001628280-25-011338:0
38,640 shares0Common StockSEC:0001628280-24-052573:0
25 of 58 declarations
